Black Diamond Therapeutics, Inc (BDTX) insider trading

Every open-market stock purchase and sale by Black Diamond Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Growth N V Biotech (Insider), $934K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.90 on Sep 23, 2026.

Recent BDTX insider trades

DateInsiderTradeValue
Sep 18, 2026Prakash Raman (Insider)Bought (not open market)$13.1K
Jun 26, 2026Shannon Campbell (Insider)Bought (not open market)—
Jun 26, 2026Garry E Menzel (Insider)Bought (not open market)—
Jun 26, 2026Ali Behbahani (Insider)Bought (not open market)—
Jun 26, 2026Kapil Dhingra (Insider)Bought (not open market)—
Jun 26, 2026Samarth Kulkarni (Insider)Bought (not open market)—
Jun 26, 2026Prakash Raman (Insider)Bought (not open market)—
Jun 19, 2026Ali Behbahani (Insider)Bought (not open market)$14.9K
Jun 19, 2026Prakash Raman (Insider)Bought (not open market)$13.1K
Mar 20, 2026Ali Behbahani (Insider)Bought (not open market)$14.9K
Mar 20, 2026Prakash Raman (Insider)Bought (not open market)$13.1K
Jan 21, 2026Erika Jones (Insider)Bought (not open market)—
Jan 21, 2026Sergey Yurasov (C-suite exec)Bought (not open market)—
Jan 21, 2026Elizabeth Buck (C-suite exec)Bought (not open market)—
Jan 21, 2026Mark A. Velleca (CEO)Bought (not open market)—
Jan 21, 2026Brent Hatzis-Schoch (Insider)Bought (not open market)—
Dec 12, 2025Ali Behbahani (Insider)Bought (not open market)$14.4K
Dec 12, 2025Prakash Raman (Insider)Bought (not open market)$12.9K

Who's trading BDTX

Get free alerts when an insider at Black Diamond Therapeutics, Inc files a new trade →